Skip to content
Pulmonary Hypertension News logo
  • HCP Portal
  • About PH
    What is pulmonary hypertension?
    Classification
    Causes
    Symptoms
    Diagnosis
    Living with PH
  • Treatments
    Approved treatments
    Experimental treatments
    • INOpulse
    • Stem cell therapy
  • News
  • Columns
    Blooming Hope — Anna Jeter
    Life as a Caregiver — Colleen Steele
    PHighting Words — Mike Naple
    Worth the PHight — Jen Cueva
    Archived columns
    • Recharged and Rewired — Brittany Foster
    • Chronically Uncool — Ellie Bird
    • In Life With PH — Serena Lawrence
    • Life After PH — Kathleen Sheffer
    • My Respiration Situation — Karen Schultz
  • Collections
    Newly diagnosed with PH
    Living well with PH
    Mental health and PH
  • Forums
  • Advocacy partners
  • What can we help you find today?

    • HCP Portal
  • Social Clips
  • Pulmonary Hypertension: Dr. Karin Halvorson

Pulmonary Hypertension: Dr. Karin Halvorson

admin avatar

by admin | March 8, 2016

Share this article:

Share article via email
  • Share on Facebook
  • Share on Twitter
  • Share on Reddit
  • Share via Email

In this video, Dr. Karin Halvorson, from Tulane University, lectures on pulmonary hypertension (PH).

Keep up to date on all the latest PH news here: https://bit.ly/20LXxHN

Print This Page

Tags

pulmonary hypertension

Recent Posts

  • I’ve discovered a new tool to avoid triggers: ‘glimmers’
  • Combination therapy effective in PAH with heart disease risk factors
  • Liquidia gets $50M more after first sale of Yutrepia to treat PH
  • Phase 3 PAH trial of ralinepag fully enrolled, results expected in 2026
  • Finding my real-life story in fictional tales told by others


Recommended reading

A patient talks with a doctor who is shown using a computer.
July 2, 2025 News by Steve Bryson, PhD

Combination therapy effective in PAH with heart disease risk factors

In this money tree illustration, bills are seen growing from the branches of a large tree.
June 30, 2025 News by Steve Bryson, PhD

Liquidia gets $50M more after first sale of Yutrepia to treat PH

Images of oral medications and a heartbeat graph illustrate the words
June 27, 2025 News by Marisa Wexler, MS

Phase 3 PAH trial of ralinepag fully enrolled, results expected in 2026

Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.